The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter

被引:149
作者
Ventura, A
Luzi, L
Pacini, S
Baldari, CT
Pelicci, PG
机构
[1] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[2] Fdn Italiana Ric Canc, Inst Mol Oncol, I-20139 Milan, Italy
[3] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy
关键词
D O I
10.1074/jbc.M200280200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammal Shc locus encodes three overlapping isoforms (46, 52, and 66 kDa) that differ in the length of their N-terminal regions. p46/p52Shc and p66Shc have been implicated, respectively, in the cytoplasmic propagation of growth and apoptogenic signals. Levels of p66Shc expression correlate with life span duration in mice. p46Shc and p52Shc are ubiquitously expressed, whereas p66Shc is expressed in a cell lineage-specific fashion. However, the mechanisms underlying the regulation of Shc protein expression are unknown. Here we report the identification of two alternative promoters, driving the transcription of two mRNAs coding for p46/p52Shc and p66Shc. We show that treatment with an inhibitor of histone deacetylases or with a demethylating agent results in induction of p66Shc expression in cells that normally do not express this isoform but leaves the levels of the two other isoforms unchanged. Moreover, analysis of the methylation pattern of the p66Shc promoter in a panel of primary and immortalized human cells showed inverse correlation between p66Shc expression and methylation density of its promoter. These results identify histone deacetylation and cytosine methylation as the mechanisms underlying p66Shc silencing in nonexpressing cells.
引用
收藏
页码:22370 / 22376
页数:7
相关论文
共 37 条
[1]  
Ahuja N, 1998, CANCER RES, V58, P5489
[2]  
Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835
[3]   HIGH-LEVELS OF DENOVO METHYLATION AND ALTERED CHROMATIN STRUCTURE AT CPG ISLANDS IN CELL-LINES [J].
ANTEQUERA, F ;
BOYES, J ;
BIRD, A .
CELL, 1990, 62 (03) :503-514
[4]  
Archey WB, 1999, CANCER RES, V59, P2292
[5]   Regulation of gene expression by alternative promoters [J].
Ayoubi, TAY ;
VanDeVen, WJM .
FASEB JOURNAL, 1996, 10 (04) :453-460
[6]  
Baylin SB, 1998, ADV CANCER RES, V72, P141
[7]   Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain [J].
Cattaneo, E ;
Pelicci, PG .
TRENDS IN NEUROSCIENCES, 1998, 21 (11) :476-481
[8]   ALTERNATIVE TRANSCRIPTION AND SPLICING OF THE HUMAN PORPHOBILINOGEN DEAMINASE GENE RESULT EITHER IN TISSUE-SPECIFIC OR IN HOUSEKEEPING EXPRESSION [J].
CHRETIEN, S ;
DUBART, A ;
BEAUPAIN, D ;
RAICH, N ;
GRANDCHAMP, B ;
ROSA, J ;
GOOSSENS, M ;
ROMEO, PH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (01) :6-10
[9]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[10]   ALTERNATIVE PROMOTER USAGE BY ALDOLASE A DURING INVITRO MYOGENESIS [J].
COLBERT, MC ;
CIEJEKBAEZ, E .
DEVELOPMENTAL BIOLOGY, 1988, 130 (01) :392-396